Oral corticosteroid use among children in TennCare

Ambulatory Pediatrics

Volumn 2, Issue 5, 2002, Pages 375-381

  Cooper, William O ^a,e   Staffa, Judy A ^d   Renfrew, J William ^c   Graham, David J ^d   Ray, Wayne A ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Asthma; Medicaid; Respiratory illness; Steroid use

Indexed keywords

BETAMETHASONE; CORTICOSTEROID; CORTISONE ACETATE; DEXAMETHASONE; FLUDROCORTISONE ACETATE; HYDROCORTISONE; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; TRIAMCINOLONE;

ADOLESCENT; AGE; ALLERGY; ARTICLE; ASTHMA; BEHAVIOR DISORDER; CATARACT; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DRUG INDICATION; DRUG USE; ENDOCRINE DISEASE; FEMALE; GENDER; GROWTH DISORDER; HUMAN; INFECTION RISK; INFLAMMATORY DISEASE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICAL DOCUMENTATION; NEUROLOGIC DISEASE; PATIENT INFORMATION; POPULATION RESEARCH; PRESCRIPTION; RACE; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; RHEUMATIC DISEASE; URBAN RURAL DIFFERENCE;

EID: 0036749103     PISSN: 15301567     EISSN: None     Source Type: Journal    
DOI: 10.1367/1539-4409(2002)002<0375:OCUACI>2.0.CO;2     Document Type: Article

References (61)

1. Blamer JL. Off-label uses of drugs in children. Pediatrics. 1999; 104:598-602.
2. American Academy of Pediatrics, Committee on Drugs. Unapproved uses of approved drugs: the physician, the package insert and the Food and Drug Administration. Pediatrics. 1996;98: 143-145.
3. Kauffman RE, Kearns GL. Pharmacokinetic studies in pediatric patients: clinical and ethical considerations. Clin Pharmacokinet. 1992;23:10-29.
4. Kaushal R, Bates DW, Landrigan C, et al. Medication errors and adverse drug events in pediatric inpatients. JAMA. 2001; 285:2114-2120.
5. Food and Drug Administration, Center for Drug Evaluation and Research: Food and Drug Modernization Act of 1997 and related documents. Available at: http://www.fda.gov/opacom/7modact.html. Accessed December 3, 2001.
6. Physician's Desk Reference: 1998. 52nd ed. Montvale, NJ: Medical Economics; 1998.
7. Cruz MN, Stewart G, Rosenberg N. Use of dexamethasone in the outpatient management of acute laryngotracheitis. Pediatrics. 1993;96:220-223.
8. Ramsey MJ, DerSimonian R, Holtel MR, Burgess LP Corticosteroid treatment for idiopathic facial nerve paralysis: a meta-analysis. Laryngoscope. 2000;200:335-341.
9. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med. 1997;336:1224-1234.
10. Alabrese LH. Therapy of systemic vasculitis. Neurol Clin. 1997; 15:973-991.
11. Emery H. Pediatric scleroderma. Semin Cutan Med Surg. 1998; 17:41-47.
12. Giannini EH, Cawkwell GD. Drug treatment in children with juvenile rheumatoid arthritis: past, present, and future. Pediatr Clin North Am. 1995;42:1099-1125.
13. Golder J. Oral steroids in the treatment of otitis externa. Austr Fam Physician. 1999;28:775.
14. Rosenfeld RM. What to expect from medical treatment of otitis media. Pediatr Infect Dis J. 1995;14:731-737.
15. Berman S. Otitis media in children. N Engl J Med. 1995;332: 1360-1365.
16. Grant CC, Duggan AK, Santosah M, DeAngelis C. Oral prednisone as a risk factor for infections in children with asthma. Arch Pediatr Adolesc Med. 1996;150:58-63.
17. Kasper WJ, Howe PM. Fatal varicella after a single course of corticosteroids. Pediatr Infect Dis J. 1990;9:729-732.
18. Lanter R, Rockoff JB, DeMasi J, et al. Varicella in a corticosteroid-dependent asthmatic receiving troleandomycin. Allergy Proc. 1990;11:83-87.
19. Scharer K, Essigmann HC, Schaefer F. Body growth of children with steroid-resistant nephrotic syndrome. Pediatr Nephrol. 1999;13:828-834.
20. Polito C, La Manna A, Papale MR, Villain G. Delayed pubertal growth spurt and normal adult height attainment in boys receiving long-term alternate-day prednisone therapy. Clin Pediatr. 1999;38:279-285.
21. Kaye LD, Kalenake JW, Price RL, Cunningham R. Ocular implications of long-term prednisone therapy in children. J Pediatr Ophthalmol Strabismus. 1993;30:142-144.
22. Nassif E, Weinberger M, Sherman B, Brown K. Extrapulmonary effects of maintenance corticosteroid therapy with alternate-day prednisone and inhaled beclomethasone in children with chronic asthma. J Allergy Clin Immunol. 1987;80:518-529.
23. Soliday E, Grey S, Lande MB. Behavioral effects of corticosteroids in steroid-sensitive nephrotic syndrome. Pediatrics. 1999. Available at: http://www.pediatrics.org/cgi/content/full/104/4/e51. Accessed March 7, 2000.
24. Dawson KL, Carter ER. A steroid-induced psychosis in a child with asthma. Pediatr Pulmonol. 1998;26:362-364.
25. Brown ES, Khan DA, Nejtek VA. The psychiatric side effects of corticosteroids. Ann Allergy Asthma Immunol. 1999;83:495-504.
26. Kennedy DL, Forbes MB. Drug therapy for ambulatory pediatric patients in 1979. Pediatrics. 1982;70:26-29.
27. Walsh LJ, Wong CA, Pringle M, Tattersfield AE. Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study. BMJ. 1996;313:344-346.
28. Newacheck PW, Taylor WR. Childhood chronic illness: prevalence, severity, and impact. Am J Public Health. 1992;82:364-371.
29. Perrin EC, Newacheck P, Pless IB, et al. Issues involved in the definition and classification of chronic health conditions. Pediatrics. 1993;91:787-793.
30. Ireys HT, Anderson GF, Shaffer TJ, Neff JM. Expenditures for care of children with chronic illnesses enrolled in the Washington State Medicaid program, fiscal year 1993. Pediatrics. 1997; 100:197-204.
31. Piper JM, Ray WA, Griffin MR. Effects of Medicaid eligibility expansion on prenatal care and pregnancy outcome in Tennessee. JAMA. 1990;264:2219-2223.
32. Strom BL, Carson JL. Use of automated databases for pharmacoepidemiology research. In: Armenian HK, Gordis L, Levine MM, Thacker SB, eds. Epidemiologic Reviews. 12th ed. Baltimore, Md: The Johns Hopkins University School of Hygiene and Public Health; 1990:87-107.
33. West SL, Savitz DA, Koch G, et al. Recall accuracy for prescription medications: self-report compared with database information. Am J Epidemiol. 1995;142:1103-1110.
34. Ray WA. Policy and program analysis using administrative databases. Ann Intern Med. 1997;127:712-718.
35. Leister KA, Edwards WA, Christensen DB. A comparison of patient drug regimens as viewed by the physician, pharmacist and patient. Med Care. 1981;19:658-664.
36. Johnson RE, Vollmer WM. Comparing sources of drug data about the elderly. J Am Geriatr Soc. 1991;39:1079-1084.
37. Ray WA, Griffin MR. The use of Medicaid data for pharmacoepidemiology. Am J Epidemiol. 1989;129:837-849.
38. Cooper WO, Hickson GB, Gray CL, Ray WA. Continuity of enrollment for infants in the first year of life and children with chronic health conditions following implementation of Tenn-Care. Arch Pediatr Adolesc Med. 1999; 153:1145-1149.
39. Forrest CB, Simpson L, Clancy C. Child health services research: challenges and opportunities. JAMA. 1997;277:1787-1793.
40. Mansour ME, Lanphear BP, DeWitt TG. Barriers to asthma care in urban children: parent perspectives. Pediatrics. 2000;106: 512-519.
41. Cooper WO, Hickson GB. Corticosteroid prescription filling for children covered by Medicaid following an emergency department visit or hospitalization for asthma. Arch Pediatr Adolesc Med. 2001;155:1111-1115.
42. Cooper WO, Federspiel CF, Griffin MR, Hickson GB. New use of anticonvulsants among children enrolled in Tennessee Medicaid. Arch Pediatr Adolesc Med. 1997;151:1242-1246.
43. International Classification of Diseases, Ninth Revision, Clinical Modification. Washington, DC: Public Health Service, US Dept of Health and Human Services; 1988.
44. Garrison MM, Christakis DA, Harvey E, et al. Systemic corticosteroids in infant bronchiolitis: a meta-analysis. Pediatrics. Available at: http://www.pediatrics.org/cgi/content/full/105/4/e44. Accessed March 29, 2002.
45. Yu ML, Ryu JH. Assessment of the patient with chronic cough. Mayo Clin Proc. 1997;72:957-959.
46. Kaliner M. Medical management of sinusitis. Am J Med Sci. 1998;316:21-28.
47. Al-Ghamdi SA, Manoukian JJ, Morielli A, et al. Do systemic corticosteroids effectively treat obstructive sleep apnea secondary to adenotonsillar hypertrophy? Laryngoscope. 1997;107: 1382-1387.
48. Sudderick RM, Narula AA. Steroids for airway problems in glandular fever. J Laryngol Otol. 1987;101:673-675.
49. Pomeranz AJ, Fairley JA. Management errors leading to unnecessary hospitalization for kerion. Pediatrics. 1994;93:986-988.
50. Kokontis L, Gutmann L. Current treatment of neuromuscular diseases. Arch Neurol. 2000;57:939-943.
51. Hunter SF, Weinshenker BG, Carter JL, Noseworthy JH. Rational clinical immunotherapy for multiple sclerosis. Mayo Clin Proc. 1997;72:765-780.
52. Ambrus JL, Sridhar NR. Immunologic aspects of renal disease. JAMA. 1997;278:1938-1945.
53. Han RK, Silverman ED, Newman A, McCrindle BW. Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease. Arch Pediatr Adolesc Med. 2000;154:695-699.
54. Gaber AO, Moore LW, Schroeder TJ. Observations on recovery of renal function following treatment for acute rejection. Am J Kid Dis. 1998;31:S47-S59.
55. Health Care Financing Administration Medicaid enrollment Web site. Available at: http://www.hcfa.gov/medicaid/medicaid.htm. Accessed May 3, 2001.
56. Mukwaya G. Immumosuppressive effects and infections associated with corticosteroid therapy. Pediatr Infect Dis J. 1988;7: 499-504.
57. Gershon A, Brunell PA, Doyle EF. Steroid therapy and varicella. J Pediatr. 1972;81:1034.
58. Dolan LM, Kersawala HH, Holroyde JC, Fischer TJ. Short-term, high-dose systemic steroids in children with asthma: the effect on the hypothalamic-pituitary-adrenal axis. J Allergy Clin Immunol. 1987;80:81-87.
59. van Staa TP, Leufekens HGM, Abenhairn L, et al. Use of oral corticosteroids in the United kingdom. QJM. 2000;93:105-111.
60. Thrane N, Sorensen HT. A one-year population-based study of drug prescriptions for Danish children. Acta Paediatr. 1999;88: 1131-1136.
61. Schirm E, van den Berg P, Gebben H, et al. Drugs use of children in the community assessed through pharmacy dispensing data. J Clin Pharmacol. 2000;50:473-478.